Hong Kong
Codex Genetics and Pacific Edge Partner to Introduce Cxbladder Genomic Urine Tests for Bladder Cancer Diagnosis in Hong Kong
Codex Genetics, one of the leading precision diagnostics companies in Hong Kong, announced an exclusive collaboration with Pacific Edge, the deve...
August 11, 2025 | News
AXA Partners with Hainan Boao Lecheng to Pioneer Innovative Cross-Border Medical Insurance Models
AXA China Region Insurance Company (Bermuda) Limited ("AXA") formally signed an official cooperation agreement with Hainan Boao Lecheng Internati...
August 11, 2025 | News
XtalPi and DoveTree Medicines Forge $5.99 Billion AI-Powered Drug Discovery Alliance
XtalPi (2228.HK), a leading global technology company in integrating artificial intelligence (AI) and robotics for drug and materials discovery, announced ...
August 07, 2025 | News
GenScript Biotech Earns MSCI AA ESG Rating, Recognised as Global Sustainability Leader
GenScript Biotech Corporation (HK.1548), a leading global provider of life science research and manufacturing services, today announced that its ESG rating...
August 04, 2025 | News
Akeso Enrols First Patient in Phase III Trial of Ivonescimab for Metastatic Pancreatic Cancer
Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is pleased to announce that the first patient has been enrolled in the pivotal/registration Phase II...
July 24, 2025 | News
WuXi Biologics China PFS Site Clears FDA Inspection
WuXi Biologics’ pre-filled syringes (PFS) commercial production line passed its first FDA inspection, paving the way for global delivery of high-qu...
July 22, 2025 | News
Akeso Begins Phase III Trial of Ivonescimab for Hard-to-Treat Advanced Colorectal Cancer
Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is pleased to announce that the first patient has been successfully enrolled in the registration Phas...
July 16, 2025 | News
Ascletis Completes Dosing in U.S. Trial of ASC47 and Semaglutide for Obesity
The combination study, conducted in the U.S., is designed to evaluate the safety, tolerability and preliminary efficacy at Day ...
July 15, 2025 | News
WuXi AppTec Issues Positive Profit Alert with Over 100% Surge in H1 2025 Net Profit
WuXi AppTec Co., Ltd., a leading global pharmaceutical and life sciences technology platform company offering integrated, end-to-end new drug R&D and m...
July 11, 2025 | News
WuXi AppTec Completes RMB1 Billion A-Share Buyback and HKD2.5 Billion H-Share Acquisition to Drive Shareholder and Talent Value
WuXi AppTec Co., Ltd, a global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the pharmaceutical and ...
July 09, 2025 | News
Akeso Doses First Patient in Phase Ia Trial of AK146D1, the World’s First Bispecific ADC Targeting Trop2 and Nectin4
Akeso, Inc. (9926.HK) ("Akeso" or the "Company") has announced the successful enrollment of the first patient in its Phase Ia clinical trial for AK146D1, a...
July 04, 2025 | News
Ascletis Doses First Participants in U.S. Phase IIa Trial of Oral Small Molecule GLP-1 Agonist ASC30 for Obesity
- First participants with obesity or overweight with at least one weight-related comorbidity have been dosed in a ...
July 03, 2025 | News
Mabwell Grants Qilu Pharmaceutical Greater China Rights to Next-Generation Long-Acting G-CSF Albipagrastim Alfa
Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced its wholly-owned subsidiary T-mab has entered into an ag...
June 30, 2025 | News
XtalPi Expands AI-Driven Drug Discovery Collaboration with Pfizer to Develop Next-Generation Molecular Modeling Platform
XtalPi (2228.HK), a leading global technology company in integrating artificial intelligence (AI) and robotics to advance the discovery of groundbreaking m...
June 30, 2025 | News
Most Read
- How Innovation Gaps in Biopharma Raise New Safety Concerns
- Smart Implants and the Future of Musculoskeletal Injury Treatment
- How Ethical Gaps in Psychiatry Could Undermine Biopharma Progress
- The Evolving Landscape of Women’s Health Innovation in the Asia-Pacific
- Using NLP-Driven Decision Support in Emergency Health Assistance
- Taiwan Steps Into the Global Spotlight With a New Cancer Therapy
- The Role of Unique Device Identification (UDI) in Tracing Medical Device Safety
- The Importance of a Patient’s Mental Health During Clinical Trials
Bio Jobs
- Avantor’s New CEO Ligner Aims to Unlock Global Potential and Deliver Shareholder Value
- AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
- Thermo Fisher, SAMRC, and South Africa’s Department of Science and Innovation Launch CATIR to Nurture Next-Gen Scientists
- Cube Biotech Appoints Former Sartorius CEO Dr. Joachim Kreuzburg to Board of Directors
- FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
- WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
News
Editor Picks
